The available evidence of the association of PI*Z and PI*S alleles with rheumatoid arthritis and their role in the pathogenesis of RA fulfilling the criteria of the American Rheumatism Association for the classification of rheumatoid arthritis. All patients were white and from north east England. The details of age range and other characteristics of this patient group have been given previously. 17 Group 2: a separate sample of 60 random patients with severe RA (grade III and IV). The criteria of severity were as given by Steinbrocker et al. 18 Group 3: 17 random pairs of siblings, identical for their histocompatibility antigens but discordant for the disease.
Group 4: a total of 145 unrelated patients with SS. The patients were divided into four subgroups: 56 patients with primary SS (P-SS); 46 patients with secondary SS with RA (SS-RA), 15 patients with secondary SS with another recognisable connective tissue disorder other than RA (Sec-SS), and 28 patients with non-systemic sicca syndrome (NS-SS).
The details of clinical features of each subgroup and criteria of classification have already been reported. 19
A random control sample of 316 individuals was derived from blood donors, individuals requested from the general electoral register, and couples referred to the Department of Human Genetics for paternity testing. PI 
SUBTYPES
The PI subtyping was performed by thin layer polyacrylamide gel isoelectric focusing using LKB Multiphor apparatus at 10°C. The gel (0-5 mm thick) contained 4-8% acrylamide, 0-15% N,N'-methylenebisacrylamide, 12% glycerol, 6% ampholine pH 4-6 (LKB), and 1-5% of 1% ammonium persulphate.
To improve the corridor between the Ml and M2 bands and to identify the intermediate M3 bands various spacer compounds listed in the Sigma catalogue were tried. 3-(N-Morpholino)propane sulphonic acid (Sigma) at a concentration of 1*54% w/v in the gel differentiated ideally between Ml, M2, and M3 bands (Fig. 1) Table 3 gives the distribution of PI phenotypes in Table 4 gives the frequency of PI phenotypes observed in four subgroups of patients with SS and controls. Compared with the control group there was no significant variation in any of the groups of patients with SS, though a slight increase in MlMl homozygous was evident in P-SS and Sec-SS groups, and of MiS phenotype in the SS-RA group. This lack of association between PI and SS is in agreement with a previous report. '6 Discussion Several studies to date have investigated a possible association between PI phenotypes and RA. Of these, only five have shown either a marginal or a significant association with Z heterozygote phenotypes (MZ and SZ) and of these, two studies have also shown an increase in the MS phenotype. Geddes and his colleagues found a significant increase of MS and MZ phenotypes in patients with RA complicated by fibrosing alveolitis but not in patients with uncomplicated RA.10 In the same study patients without RA but with fibrosing alveolitis also showed a significant increase in MZ phenotype. A more recent report from Pittsburgh, however, failed to confirm this association in their patients with RA and interstitial pulmonary fibrosis.12 The balance of the available studies is, therefore, in agreement with our present results, i.e., in failing to show an increase in the frequency of the non-M alleles of the PI system in patients with RA and severe RA. We therefore support the view that any increase in the frequency of the Z allele may be related to associated pulmonary manifestations such as fibrosing alveolitis, and that the Z allotype has little or no contribution to the frequency or severity of RA.
On the other hand, the results of the recent studies of PI subvariant in patients with RA have shown an interesting association with M subtypes. Our results show an increase in the MiM2 phenotype in both RA and severe RA groups, and a protective role of the M3 allotype. Our sib pair analysis also reinforces this observation of an increase in the M1M2 phenotype and suggests that this increase is independent of an association with the HLA-DR4 phenotype. Our results are in general agreement with those of Sander and coworkers, who also showed a significant increase in the M1M2 phenotype. ' At present it is very difficult to present any convincing explanation of the association of M2 subvariants because the in vitro functional assessment of M subvariants does not show any significant variation in their ability to inhibit elastase or trypsin. As the PI protein has a wide spectrum of inhibition activity a further functional investigation of M subvariants may be warranted. To account for the variation of association in different continental populations in future it will be necessary to consider the population structure of both the control and patient groups. Samples studied from a relatively inbred population may show a homozygous excess as seen in the Australian survey.14 A genetic predisposition to disease due to an additive effect of alleles present on different parts of human genome has been suggested. For RA, in addition to the association with HLA (DR4), an association with Gm allotypes has been reported. 20 21 The Gm and PI alleles are linked and situated on chromosome 14. To determine whether the PI alleles are directly involved in the development of RA or are in linkage disequilibrium with another susceptibility locus on chromosome 14 would require a further investigation of chromosome 14 markers in patients with RA with and without pulmonary complications. To resolve the association between RA and M subtypes further analysis with a more refined isoelectric focusing technique using immobilines is necessary. 
